Effects of Plant Stanol Esters on Blood Flow (BLOOD FLOW)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by Helsinki University.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Finnish Institute of Occupational Health
Information provided by:
Helsinki University
ClinicalTrials.gov Identifier:
NCT01315964
First received: March 15, 2011
Last updated: NA
Last verified: February 2011
History: No changes posted

March 15, 2011
March 15, 2011
February 2011
December 2011   (final data collection date for primary outcome measure)
Structure and function of the arterial wall [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]
Same as current
No Changes Posted
serum composition of fats [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
Effects of Plant Stanol Esters on Blood Flow
Effects of Dietary Plant Stanol Esters of Blood Flow Among Healthy Adult Human Subject. The BLOOD FLOW -Study

Plant stanol esters as part of daily diet can decrease serum level of LDL-cholesterol up to 10%. This decrease diminishes the risk of development of premature atherosclerosis and it´s complications (e.g., acute myocardial infarction) in adult human subjects.

The purpose of the present study is to evaluate among healthy human subjects (N=100) effects of plant stanol esters (3 grams/day for 6 months) as part of daily diet in margarine on arterial endothelial cells, arterial stiffness, autonomic innervation of the arteries, arterial blood flow and serum fats. The non-invasive arterial measurements (VaSera®, EndoPat® and WinCRPS®) are performed and blood samples are taken at the beginning and at the end of the 6-month-long study period. Also questionnaires concerning healthy, and life and dietary habits are fulfilled. Dietary records (twice for a 3-day-period) are done.

Hypothesis of the study is that a dietary serum cholesterol lowering intervention has beneficial influence on the early prognostic markers of premature atherosclerosis.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Basic Science
Atherosclerosis
Dietary Supplement: plant stanol ester
3 gr of plant stanol esters per day in a margarine product as part of daily diet for a period of 6 months
Other Name: Benecol
  • Active Comparator: plant stanol ester
    3 grams of plant stanol esters per day in a margarine product as part of daily diet for 6 months
    Intervention: Dietary Supplement: plant stanol ester
  • Placebo Comparator: Placebo
    a margarine product as part of daily diet, which is not containing plant stanol esters
    Intervention: Dietary Supplement: plant stanol ester
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
100
December 2011
December 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • healthy human subjects

Exclusion Criteria:

  • abnormal liver, kidney and thyroid function
  • unstable myocardial disease
  • inflammatory bowel disease
  • alcohol abuse
  • pregnancy
  • any lipid-lowering medication
Both
18 Years to 70 Years
Yes
Contact: Helena Gylling, Professor +358 0 471 71850 helena.gylling@hus.fi
Contact: Markku J. Nissinen, Docent +358 0 471 71850 markku.nissinen@hus.fi
Finland
 
NCT01315964
3352
No
Markku Nissinen, Dept. of Medicine, Div. of Gastroenterology, Helsinki Univ. Central Hospital
Helsinki University
Finnish Institute of Occupational Health
Study Director: Markku J Nissinen, MD Docent Dept. of Medicine, Div. of Gastroenterology, Helsinki Univ. Central Hospital
Helsinki University
February 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP